13. Other (Income) Expense, Net
The components of other (income) expense, net, for the following years ended December 31 are:
| 2013 | 2012 | 2011 | ||||||||||
| (dollars in millions) | ||||||||||||
|
Interest income |
$ | (1.3 | ) | $ | (5.5 | ) | $ | (3.5 | ) | |||
|
Foreign exchange losses (gains) |
4.4 | (0.7 | ) | 2.0 | ||||||||
|
Gore Proceeds |
(894.3 | ) | — | — | ||||||||
|
Litigation charges, net |
428.0 | — | 246.5 | |||||||||
|
Gain on the EP Sale |
(213.0 | ) | — | — | ||||||||
|
Contribution to C. R. Bard Foundation, Inc. |
25.0 | 2.5 | 2.2 | |||||||||
|
Divestiture-related charges |
17.5 | — | — | |||||||||
|
Asset impairments |
6.4 | 22.2 | — | |||||||||
|
Restructuring |
(2.1 | ) | 17.4 | 7.8 | ||||||||
|
Acquisition-related items |
11.3 | 2.1 | 4.4 | |||||||||
|
Impairment charges for bonds |
— | — | 11.5 | |||||||||
|
Other, net |
(1.2 | ) | 2.3 | 1.0 | ||||||||
|
|
|
|
|
|
|
|||||||
|
Total other (income) expense, net |
$ | (619.3 | ) | $ | 40.3 | $ | 271.9 | |||||
|
|
|
|
|
|
|
|||||||
Gore Proceeds—See Note 10 of the notes to consolidated financial statements.
Litigation charges, net—In 2013, the amount reflected estimated costs for product liability matters, net of recoveries, and other litigation matters. In 2011, the amount reflected the estimated costs of settling all Hernia Product Claims (other than the putative class action lawsuits), including costs to administer the settlements, and the charge associated with the preliminary agreement to resolve claims with respect to the Brachytherapy Matter. The amount for 2011 also reflected certain other legal settlements and commitments. See Note 10 of the notes to consolidated financial statements.
Gain on the EP Sale—See Note 2 of the notes to consolidated financial statements.
Contribution to C. R. Bard Foundation, Inc.—The amounts represent annual contributions to the C. R. Bard Foundation, Inc.
Divestiture-related charges—The amount reflected separation costs incurred in connection with the EP Sale. See Note 2 of the notes to consolidated financial statements.
Asset impairments—See Note 3 of the notes to consolidated financial statements.
Restructuring—See Note 3 of the notes to consolidated financial statements.
Acquisition-related items—The amounts consist of acquisition-related integration costs. See Note 2 of the notes to consolidated financial statements.
Impairment charges for bonds—See Note 6 of the notes to consolidated financial statements.